The bill aims to expand and modernize cord blood and transplant program capacity—potentially improving access to life‑saving transplants—but does so by increasing authorized spending and regulatory requirements while leaving actual funding contingent on future appropriations.
Patients who need bone marrow, stem cell, or cord blood transplants may gain improved access to matched units and greater transplant capacity because the bill raises annual authorized funding and modernizes/expands the national cord blood inventory.
Hospitals and transplant centers could receive steadier federal support and clearer statutory guidance for registry, matching, and cord blood inventory operations, which could improve transplant program planning and patient placement.
Taxpayers may face higher federal costs because the bill increases authorized annual spending and could mandate expanded collection/storage/purchase of cord blood units if appropriated.
Patients and hospitals may not see the intended benefits if Congress does not actually appropriate the higher authorized amounts, because authorization alone does not guarantee funding.
Cord‑blood banks and nonprofit organizations could face new compliance, reporting, or operational burdens from expanded inventory standards, increasing their costs and administrative workload.
Based on analysis of 3 sections of legislative text.
Authorizes $33,009,000 annually for the C.W. Bill Young Cell Transplantation Program for FY2027–FY2031 and replaces statutory language on cord blood inventory.
Introduced September 4, 2025 by Christopher Henry Smith · Last progress September 4, 2025
Amends federal law to continue and raise authorized funding for the C.W. Bill Young Cell Transplantation Program and replaces language governing the cord blood inventory. It keeps the currently authorized $31,009,000 level for FY2022–FY2026, adds an authorization of $33,009,000 per year for FY2027–FY2031, and updates the statute text that governs cord blood inventory requirements (specific replacement text not provided).